February 2007 adverse event reports that FDA received in the month

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on 2 Oct 2026. The data have the reports that FDA received through 30 Jun 2026.

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.
Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on 2 Oct 2026.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports received

In February 2007, FDA received 20,336 drug adverse event reports. In February 2006, FDA received 22,513.

In February 2007, FDA received 11,987 medical device reports. In February 2006, FDA received 9,527.

By drug reports received, February 2007 was number 7 of the 12 months of 2007. FDA received 20,129 drug reports a month on average in the 12 months before February 2007.

Receive date

A month is the month in which FDA first received the report, not the month of the event. A report about an event of an earlier year is in the month in which it came to FDA.

Data version

FAERS release of 29 Oct 2026. MAUDE release of 23 Oct 2026.

Drug reports, three years

Drug reports that FDA received each month, 36 months to February 2007

Drugs in the reports

The table has the 67 drug pages with 50 or more reports in February 2007. The rows are in order of name. A drug page with fewer reports is not in the table.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Drugs that the reports of February 2007 name as a suspect product, in order of name
Drug	Reports in the month
Accutane	165
Acetaminophen	50
Angiomax	78
Apokyn	73
Aspirin	78
Avastin	117
Avonex	219
Betaseron	77
Bextra	206
Byetta	3,058
Carboplatin	76
Celebrex	107
Chantix	102
Cisplatin	73
Coumadin	63
Cyclophosphamide	83
Cymbalta	85
Dexamethasone	51
Diovan	62
Enbrel	186
Evista	88
Fluorouracil	65
Forteo	136
Fosamax	78
Gleevec	51
Glucophage	194
Humira	153
Ibuprofen	64
Imitrex	271
Isotretinoin	62
Januvia	531
Lamictal	1,725
Lantus	65
Levaquin	54
Levemir	192
Lipitor	107
Lisinopril	64
Lyrica	173
Metformin hcl	90
Methotrexate	103
Mirena	373
Nexavar	132
Novolog	63
Oxaliplatin	60
Paroxetine hydrochloride	206
Paxil	543
Peg-Intron	57
Plavix	91
Prednisone	66
Premarin	52
Rebif	99
Remicade	293
Revlimid	100
Ribavirin	57
Risperdal	67
Rozerem	202
Seroquel	121
Seroxat	226
Sutent	52
Valtrex	482
Velcade	54
Venlafaxine hydrochloride	50
Warfarin sodium	86
Xolair	66
Zocor	110
Zometa	142
Zyprexa	134

Reaction terms in the reports

The table has the 119 reaction terms with 100 or more reports in February 2007. The rows are in order of name. One report can record more than one term.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Reaction terms that the drug reports of February 2007 record, in order of name
Reaction term (MedDRA) and plain meaning	Reports in the month
Abdominal distensiona bloated abdomen	174
Abdominal painstomach or belly pain	260
Abdominal pain upperupper stomach pain	216
Abortion spontaneousmiscarriage	108
Aggressionaggressive behaviour	181
Agitationrestlessness	133
Alanine aminotransferase increasedraised liver enzyme (ALT)	153
Alopeciahair loss	138
Amnesiamemory loss	131
Anaemialow red blood cells	209
Anorexia	239
Anxietyanxiety	329
Arthralgiajoint pain	224
Aspartate aminotransferase increasedraised liver enzyme (AST)	149
Astheniaweakness or lack of energy	430
Back painback pain	162
Balance disorderproblems with balance	109
Blood creatinine increasedraised creatinine, a kidney test	119
Blood glucose decreasedlow blood sugar reading	467
Blood glucose increasedraised blood sugar reading	1,542
Blood pressure decreaseda low blood pressure reading	111
Blood pressure increaseda raised blood pressure reading	157
Cardiac arrestthe heart stopped	108
Cardio-respiratory arrestthe heart and breathing stopped	135
Cerebrovascular accidentstroke	250
Chest discomfortchest discomfort	108
Chest painchest pain	233
Chillschills or shivering	159
Completed suicidedeath by suicide	258
Condition aggravatedthe condition being treated got worse	301
Confusional stateconfusion	248
Constipationconstipation	213
Convulsion	325
Coughcough	156
Deaththe patient died; cause not stated by this term	566
Decreased appetitereduced appetite	470
Deep vein thrombosisa blood clot in a deep vein	101
Dehydrationdehydration	187
Depressed level of consciousness	102
Depressionlow mood	345
Diabetes mellitusdiabetes	110
Diarrhoealoose or frequent stools	610
Dizzinesslight-headedness or unsteadiness	713
Drug effect decreasedthe medicine had less effect	196
Drug exposure during pregnancythe medicine was taken during pregnancy	305
Drug ineffectivethe medicine did not work as expected	982
Drug interactionan interaction between medicines	231
Drug toxicity	105
Drug withdrawal syndromesymptoms on stopping a medicine	484
Dysgeusiaaltered taste	133
Dyspepsiaindigestion	166
Dysphagiadifficulty swallowing	108
Dyspnoeashortness of breath	504
Erythemaskin redness	164
Falla fall	300
Fatiguetiredness	524
Feeling abnormalfeeling odd or not right	356
Gait disturbancedifficulty walking	140
Haemoglobin decreasedlow haemoglobin	127
Headachehead pain	669
Heart rate increaseda fast heart rate reading	168
Hyperhidrosisexcessive sweating	258
Hypersensitivityan allergic-type reaction	178
Hypertensionhigh blood pressure	202
Hypoaesthesianumbness	152
Hypoglycaemialow blood sugar	136
Hypotensionlow blood pressure	241
Influenza like illnessflu-like symptoms	116
Injection site bruisingbruising where the injection was given	168
Injection site haemorrhagebleeding where the injection was given	116
Injection site painpain where the injection was given	182
Insomniadifficulty sleeping	321
Irritabilityirritability	100
Loss of consciousnesspassing out	231
Malaisegeneral feeling of being unwell	291
Medication errora mistake in prescribing, dispensing or taking a medicine	254
Memory impairmentmemory problems	109
Muscle spasmsmuscle cramps	138
Muscular weaknessmuscle weakness	115
Myalgiamuscle pain	202
Myocardial infarctionheart attack	255
Nasopharyngitisa cold	101
Nauseafeeling sick	1,577
Nervousnessnervousness	102
Neutropenialow neutrophils, a type of white blood cell	107
Oedema peripheralswelling of the legs, ankles or hands	215
Osteonecrosis	146
Overdosea dose above the recommended amount	210
Painpain, site not specified	300
Pain in extremitypain in an arm or leg	183
Palpitationsawareness of the heartbeat	121
Pancreatitisinflammation of the pancreas	121
Paraesthesiatingling or pins and needles	188
Pharmaceutical product complaint	368
Platelet count decreasedlow platelet count	132
Pneumonialung infection	267
Pruritusitching	339
Pulmonary embolisma blood clot in the lung	130
Pyrexiafever	420
Rashskin rash	814
Renal failurekidney failure	204
Renal failure acute	241
Rhabdomyolysismuscle breakdown	149
Sepsisa severe body-wide response to infection	124
Somnolencedrowsiness	285
Stevens-Johnson syndromea severe skin and mucous-membrane reaction	127
Suicidal ideationthoughts of suicide	174
Suicide attempta suicide attempt	173
Syncopefainting	137
Tachycardiafast heart rate	119
Thrombocytopenialow platelets	141
Tremorshaking	362
Urticariahives	164
Uterine perforationa hole in the wall of the womb	169
Vision blurredblurred vision	169
Vomitingbeing sick	768
Weight decreasedweight loss	1,330
Weight increasedweight gain	250
White blood cell count decreasedlow white cell count	115

Devices in the reports

The table has the 57 device pages with 25 or more reports in February 2007. The rows are in order of name. A device page with fewer reports is not in the table.

FDA says:

MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices.
Source: openFDA, Manufacturer and User Facility Device Experience. The site read the page on 2 Oct 2026.

Device brand names that the device reports of February 2007 name, in order of name
Brand name	Reports in the month
840 Ventilator	40
Accu-Chek Aviva Test Strips	40
Accu-Chek Comfort Curve Test Strips	234
Accu-Chek Compact Test Drum	76
Aed Plus	48
Animas Insulin Infusion Pump	46
CADD Medication Cassette Reservoir	25
Coaguchek S System	80
Collamer Ultraviolet-Absorbing Posterior Chamber Three Piece	28
Contak Renewal	151
Contak Renewal 3	286
Contak Renewal 3 Rf	82
Contak Renewal 3 Rf He	57
Contak Renewal 4	28
Cypher Sirolimus-Eluting Coronary Stent	205
Endotak Reliance	99
Endotak Reliance G	127
Flextend Is-1 Bi Positive Fix	143
Freestyle	258
Freestyle Flash	620
Ge Oec 9800	62
Ge Oec 9900	26
GORE EXCLUDER AAA Endoprosthesis	29
Harmonic Ace 36 Cm	48
HiRes 90K	27
Indura	37
Inratio	48
Insignia Entra	25
Insignia Plus	50
Insignia Ultra	44
Ligaclip Endoscopic Rotating Multiple Clip Applier 20 Large	35
M Series	171
Maverick2 Monorail Ptca Catheter	52
Medtronic	29
Microstaar Injector	28
Microstaar Injector Cartridge	28
Nucleus 24 Channel Cochlear Implant System	41
Ortho Summit Sample Handling System	33
Ot Ultra Meter	43
Precision?	52
Rsvr Prdgm	38
Silicone Advance Optic Lens	35
Silicone Ultraviolet-Absorbing Posterior Chamber Three Piece	25
Softclix Lancet Device	33
Softclix Plus Lancet Device	26
Starclose Vascular Closure System	167
Synchromed El	60
Taxus Express2 Paclitaxel-Eluting Coronary Stent System	190
Tension Free Vaginal Tape	46
Ultracision Harmonic Ace	29
Ultraflex Infusion Set	49
Vitality 2 Vr	35
Vitality Avt	141
Vitality Avt Fast-Charge	34
Vitality Ds	64
Vitality Ds Vr	39
Vitality Vr	46

Cite this page

Reported Reactions. February 2007: adverse event reports received by FDA. https://reportedreactions.com/month/2007-02/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of 29 Oct 2026. Reports received through 30 Jun 2026.

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The device counts come from the openFDA Device Adverse Event (MAUDE) bulk files, release of 23 Oct 2026. The files have the reports that FDA received through 30 Sep 2026. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

Can the count for February 2007 change?

Yes. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases. This page has the count of the openFDA release of 29 Oct 2026: 20,336 drug reports.

Does a month with many reports mean that something occurred in that month?

Not by itself. The date is the date on which FDA received the report, not the date of the event. FDA says:

Many factors can influence whether or not an event will be reported, such as the time a product has been marketed and publicity about an event.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

How does a person report an adverse event?

FDA runs MedWatch, a program that takes voluntary reports from health professionals, patients and consumers. The guide on how to report has the links.

To the top of the page